The Journal of Pediatric Research

De Novo CHRNE Mutation: Congenital Myasthenic Syndrome []
. 2019; 6(4): 0-0

De Novo CHRNE Mutation: Congenital Myasthenic Syndrome

Hande Gazeteci Tekin1, Sanem Yilmaz2, GÜL AKTAN2, Sarenur Gokben2
1Çiğli Regional Training Hospital, Pediatric Neurology, İzmir,Turkey
2Ege University, Department of Pediatric Neurology,İzmir, Turkey

Congenital myasthenic syndromes (CMS) are neuromuscular hereditary diseases with the symptoms of fatigue, weakness, ptosis, ophthalmoparesis, respiratory problems. This disease group is classified as congenital myasthenic syndromes originating from the presynaptic region, synaptic gap and postsynaptic region according to the origin of the neuromuscular junction. Most of the patients are affected by receptor defects originating from the postsynaptic gap.
Here we presented a case who was thirteen years old and had CHRNE genotype p.Y124 * (c.372C> G) homozygous mutation, which was associated with weakness, low voice, ophthalmoparesis, frequent respiratory infection since birth.
Our patient has compliance with non-kinetic AChR deficiency and the case is important with the detection of a new mutation.Keywords: acetylcholine receptor deficiency, congenital myasthenic syndrome

Keywords: acetylcholine receptor deficiency, congenital myasthenic syndrome, children


Hande Gazeteci Tekin, Sanem Yilmaz, GÜL AKTAN, Sarenur Gokben. De Novo CHRNE Mutation: Congenital Myasthenic Syndrome. . 2019; 6(4): 0-0

Corresponding Author: Hande Gazeteci Tekin, Türkiye


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar